BACKGROUND: Living kidney donors (LKD) allow for increased access to lifesaving organs for transplantation. There is a relative paucity of African American (AA) live kidney donors. The prevalence of medical disease in LKD candidates has not been well studied. We examined the medical limitations to living kidney donation in a large Midwestern transplant center. METHODS: A total of 2519 adults (age ≥ 18) evaluated as potential LKD (PD) between January 1, 1996 and June 30, 2006 were prospectively followed until evaluation outcome (completed live donation, medical exclusion from live donation, non-medical exclusion from live donation). Logistic regression was used to examine the effect of age on donor exclusion, and chi-square tests were used to compare the likelihood of donor exclusions between racial and gender groups. RESULTS: Sixty percent of PD were female (n = 1300), and 86% were Caucasian (CA) (n = 1862). Overall, 48.7% of PD who underwent evaluation became LKD. The odds of donation were 52% lower in AA compared to CA (OR 0.48 p < 0.001). Among PD excluded from donation, the most common medical diagnoses were hypertension (HTN) (24.7%), inadequate creatinine clearance (10.6%) and a positive final crossmatch (10.5%). The rate of PD exclusion for obesity was twofold higher in AA compared to CA (12.8% vs. 5.8%, p < 0.001). CONCLUSIONS: Hypertension in PD is equally significant barrier to living kidney donation in AA and CA whereas obesity is a greater barrier in AA.
BACKGROUND: Living kidney donors (LKD) allow for increased access to lifesaving organs for transplantation. There is a relative paucity of African American (AA) live kidney donors. The prevalence of medical disease in LKD candidates has not been well studied. We examined the medical limitations to living kidney donation in a large Midwestern transplant center. METHODS: A total of 2519 adults (age ≥ 18) evaluated as potential LKD (PD) between January 1, 1996 and June 30, 2006 were prospectively followed until evaluation outcome (completed live donation, medical exclusion from live donation, non-medical exclusion from live donation). Logistic regression was used to examine the effect of age on donor exclusion, and chi-square tests were used to compare the likelihood of donor exclusions between racial and gender groups. RESULTS: Sixty percent of PD were female (n = 1300), and 86% were Caucasian (CA) (n = 1862). Overall, 48.7% of PD who underwent evaluation became LKD. The odds of donation were 52% lower in AA compared to CA (OR 0.48 p < 0.001). Among PD excluded from donation, the most common medical diagnoses were hypertension (HTN) (24.7%), inadequate creatinine clearance (10.6%) and a positive final crossmatch (10.5%). The rate of PD exclusion for obesity was twofold higher in AA compared to CA (12.8% vs. 5.8%, p < 0.001). CONCLUSIONS:Hypertension in PD is equally significant barrier to living kidney donation in AA and CA whereas obesity is a greater barrier in AA.
Authors: M R Tankersley; R S Gaston; J J Curtis; B A Julian; M H Deierhoi; V K Rhynes; S Zeigler; A G Diethelm Journal: Transplant Proc Date: 1997-12 Impact factor: 1.066
Authors: L Ebony Boulware; Lloyd E Ratner; Julie Ann Sosa; Lisa A Cooper; Thomas A LaVeist; Neil R Powe Journal: Transplantation Date: 2002-05-27 Impact factor: 4.939
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: Bryan D Hinck; Bryan D Naelitz; Brielle Jackson; Mariah Howard; Amy Nowacki; Charles S Modlin Journal: J Racial Ethn Health Disparities Date: 2016-06-28
Authors: Steven Habbous; Eric McArthur; Stephanie N Dixon; Susan McKenzie; Carlos Garcia-Ochoa; Ngan N Lam; Krista L Lentine; Christine Dipchand; Kenneth Litchfield; Mehmet A Begen; Sisira Sarma; Amit X Garg Journal: Transplantation Date: 2018-07 Impact factor: 4.939
Authors: Margaux N Mustian; Michael Hanaway; Vineeta Kumar; Rhiannon D Reed; Brittany A Shelton; Raynesha Grant; Alexis Carter; Jayme E Locke Journal: J Surg Res Date: 2019-07-03 Impact factor: 2.192
Authors: F L Weng; D C Lee; N Dhillon; K N Tibaldi; L A Davis; A M Patel; R J Goldberg; M Morgievich; S Mulgaonkar Journal: Transplant Proc Date: 2016 Jul-Aug Impact factor: 1.066
Authors: Deonna R Moore; David Serur; Dianne LaPointe Rudow; James R Rodrigue; Rebecca Hays; Matthew Cooper Journal: Clin J Am Soc Nephrol Date: 2015-08-12 Impact factor: 8.237
Authors: Rhiannon D Reed; Deirdre Sawinski; Brittany A Shelton; Paul A MacLennan; Michael Hanaway; Vineeta Kumar; Dustin Long; Robert S Gaston; Meredith L Kilgore; Bruce A Julian; Cora E Lewis; Jayme E Locke Journal: Transplantation Date: 2018-12 Impact factor: 4.939